Full Text View
Tabular View
No Study Results Posted
Related Studies
A Phase 1 Dose-Escalation Study of OSI-906 and Erlotinib (Tarceva®)
This study is currently recruiting participants.
Study NCT00739453.   Last updated on April 17, 2009.
Information provided by OSI Pharmaceuticals
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Advanced Solid Tumors
Interventions listed in this trial
OSI-906 and/or erlotinib
Additional drug interventions recognized in this trial
Erlotinib
More general drug interventions related to this trial
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protein Kinase Inhibitors
Sponsors listed in this trial
OSI Pharmaceuticals


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services